Established in 1978, Biocon Limited, is India's largest, and Asia's leading, biotechnology company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation-driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide. We develop, manufacture and deliver a rich portfolio of Small Molecules APIs & Formulations and Complex Biologics - both Novels and Biosimilars - including MAbs, rh-insulin& Insulin Analogs. Biocon's robust product portfolio includes the world's first Pichia-based recombinant human Insulin, INSUGEN, Glargine, BASALOG and India's first biologic BioMAb-EGFR; for head and neck cancer. It has now successfully developed its second novel biologic Itolizumab, a 'first in class' anti-CD6 monoclonal antibody, being introduced as Alzumab; for psoriasis in India, in 2013.
Biodue SpA was founded in 1986 by Sion Fulvio Benedetti and develops manufactures and distributes Medical devices, Skin cosmetics and Dietary supplements (in solid and liquid forms). In 2017, Biodue reached a turnover above 36 Million Euros and about 170 employees. The plants and warehouses cover almost 17.000 square meters and all of them are located in an industrial area near Florence. The company has two main core businesses: the Industrial division, focused on contract manufacturing and the Brand division, focused on the commercialization and promotion of the company's own products. Within the Brad division, there are three Brands: Selerbe's portfolio, based on herbal products, promoted to pharmacies; Pharcos' portfolio, including medical devices, food supplements and cosmetics, promoted to dermatologists and Biofta's portfolio, including medical devices and food supplements, promoted to oculists/ophthalmologists. The company commercialize and promote its own products directly in Italy and through JVs in US and Latam; the company has in place agreements with local/regional partners in several geographic areas not covered directly. The company has recently developed and patented in EU and US an innovative technology - RewCap® - applicable to vaginal douche, mono-dose food supplements, drops food supplements and mono-dose medical devices. The company is registered under EC Regulation number 852/2004 and under GMP (Good Manufacturing Practices) certification. The company is also registered with the US Food and Drug Administration (U.S. FDA Registration no.10725095718). From May 2015, BioDue S.p.A. is listed on the Italian stock exchange in the AIM sector. The Company received the ISO 13485 certification for the development, manufacturing and production of medical devices.
BIOFAC is an innovative company with almost 70 years of manufacturing expertise supplying natural bulk ingredients to our customers within the pharmaceutical, the nutraceutical and the cosmetics industries worldwide. All our factories are located in Denmark. For decades, all factories of the BIOFAC Group have been implementing and working under the GMP and GLP guidelines. Our products are controlled by possibly the strictest veterinary authorities in the world. These high standards enable us to supply the highest quality products available. Our product includes: Thrombin, Bionuclease, Pepsin, Thymomodulin, Placenta Extracts, Hem-Iron, Prostate Extract, Peptones, Peptides, Artificial Saliva and Lactulose.
extremely modern pharmaceutical plant, which manufactures antibiotics,
sulfonamides, compound feeds, dietary supplements, syrups, ointments and
creams, suppositories and vaginal globules. Our plants have integrated quality
assurance systems such as: GMP, HACCP, ISO 9001:2008. Moreover, one of them has
CE certificate for medical devices according to EN ISO 13485:2012 and AC 2012
and Medical Device Directive 93/42/EEC. Biofaktor performs contractual
production of medicinal products and dietary supplements for various
clients around the world.
We have successfully finished over 200 projects related both to development and manufacturing of the products of various categories.
Biofaktor has a huge possibilities and rich experience in product development, laboratory analysis, drawing up documentations and final production. Our expertise covers all major product groups, namely:
- food supplements,
- medical devices,
- OTC medicines,
- RX medicines,
We are also experienced in additional services:
- formal management of technology transfer,
- process adaptation if required,
- pilot runs,
- stability tests,
- full scale production,
- release analysis,
- tablets (various sizes, shapes, film and sugar coated),
- hard gelatin capsules (sizes: 1, 0, 00),
- granules (incl. coated granules),
- suppositories, vaginal globules,
- non sterile liquids,
- emulsions, balms
- blisters Alu/Alu,
- various containers with different pumps, applicators (incl. Oral and nasal)
sachets for: ointments, gels,
Biofarm is a leading family-owned Polish pharmaceutical manufacturer. All our products are GMP compliant and manufactured within the EU. Our portfolio of market leaders and innovative products contains over 60 prescription medicines, OTC medicines and dietary supplements. We are seeking long-term collaboration in various forms (distribution and licence in/out).
Biofarma, founded in 1945, is one of the oldest pharmaceutical companies of Turkey. Biofarma, which was taken over by Pharmacist Mustafa Oncel in 1973 and then transferred into a limited company, has always improved its facilities and specialized in the production of human drugs. Our mission as Biofarma is to produce quality generic drugs at world standards (cGXP) with a respect of environment and awareness of social responsibility.
Biofarma is a contract manufacturer for the cosmetic, food supplement and medical device industries, producing various forms and packaging. Biofarma guarantees a full service, developing any kind of formula to satisfy the requests of clients from all over the world. Biofarma holds the following certifications: ISO:22716, FDA, ISO:13485, ISO:9001, and an ICEA certification.
Biofer S.p.A. is an Italian independent Company, specialized in the manufacturing of both APIs and Dosage Forms. Biofer complies to the highest GMP standards, always paying great attention to detail in all quality aspects. Among its Products: Iron Complexes, Heparins/Heparinoids, Steroids, Enzymes, Folinates and Miscellaneous.
BioFilm has established an excellent reputation for developing and manufacturing thin dissolvable films (TDF) which release active ingredients. A range of actives can be incorporated into the films and the products can be classified as nutritional supplements, cosmetic, dental, medical devices through to medicinal and pharmaceutical. In fact, we produce more products in TDF than any other European manufacturer. BioFilm can offer companies a true partnership which allow us to take innovative concepts right through from initial research to development, manufacture, packaging and final delivery to the retailer. Thus enabling partners to launch innovative products quickly and cost effectively. Contact us today to learn more to discuss potential collaborations.
BioGrowing is a group company dedicated to the probiotic business, starting with brand probiotic formulations in the China market 20 years ago, and expanded from supplement formulations to dairy, functional foods and agriculture probiotics.
Business Scope: probiotic strains in bulk; probiotic blends/premix; probiotic formulations in bulk; probiotic formulations in private labels; dairy starter cultures; functional foods products; and feed additives and agricuture probiotics.
Here are our products and services:-
For commercial probiotic products
Bulk probiotic strains (Lactic Acid Bacteria)
Probiotic supplements in capsules, sachets/strips, powder formulations.
Dairy starter cultures for yoghurt, yoghurt drink, sour cream, soft cheese, cottage cheese etc.
Food probiotic programs, include bakery, drinks, dairy products
Animal nutrition probiotics, feed additives and starter cultures, agriculture probiotics
For market services
Biogrund assists the pharmaceutical and related industries in the development and production of solid oral dosage forms. We help our customers improve running production processes and cooperate with them in the research for new solutions. Filmcoating excellence is Biogrund's core business. Our unique and ready-to-use film coating, sugar-coating, tabletting and excipient premixes guarantee optimized results in a short time. Customized film coating systems for fast, enteric and sustained release. Since 2013 EXCiPACT™ certified. In 2014 we opened our US facility (office, lab & production site).
Our patented, safe and unique Acetium products, patient-friendly GastoPanel blood test and BIOHIT quick tests provide a purpose-built range for gastrointestinal diagnosis and stomach health.
Our core competence is based on
Our clinical trials are aiming at
- prevention of migraine type headache
- treatment of atrophic gastritis indications and
- smoking cessation
is a leading Thai pharmaceutical company specialized in the manufacture of a
wide variety of pharmaceutical formulations, including sterile preparations
(small volume liquids and powders), tablets, capsules, powder, liquids,
ointments and creams. Thanks
to our innovations of new generic products and a continuous quality improvement
that allow us to maintain the position of leadership, BIOLAB has become
synonymous with “world class quality”. Our current facilities can support the manufacturing of
niche products, including sterile powder products, lyophilized products and combined hormonal
respect to the contract manufacturing services, we deliver customized services
that respond well to various demands of customers. BIOLAB is
entrusted by renowned Thai and international customers, including Germany,
Japan, Italy, Malaysia, Singapore, Philippines, and Sri Lanka as a contract
manufacturer of their pharmaceutical products. We continue to expand our
presence in global markets and are devoted to satisfying customers with our
quality products and services.
Biolab is one of the 10 largest pharmaceutical companies in Brazil. Biolab counts on over 2000 dynamic and entrepreneurial professionals who anticipate market needs and dedicate continuously to evolution. Biolab is committed to the future and, therefore, we invest 10% of our revenues in R&D and innovation. The strategic partnerships with companies, universities and research centers worldwide strengthen our international representation. Leader in the Brazilian market of prescription drugs in the field of cardiology, Biolab has a portfolio of over 100 products and has significant activities in the areas of gynecology, dermatology, gastroenterology, rheumatology, orthopedics, pediatrics and dermocosmetics.
Biological E Limited established in 1953, leading manufacturer of Human vaccines Tetanus, DT, DTP, Td HepatitisB, DTP-HepB-Hib Pentavalent, Hib, IPV, Japanese encephalitis, Measles and Rubella, Tetanus Antitoxin and Snake Antivenin. Attained WHO prequalification for Tetanus, DTPHepBHib, JE, DTP and Td. APIs – Noscapine Base and HCL (Alkaloids) and Heparin Sodium. Pipeline Injectables - Heparin Inj, LMWH Enoxaparin, Dalteparin, Fosaprepitant, Daptomycin, Risperidone and Paliperidone Palmitate.
Since 1971, Biomerica has developed, manufactured, and distributed medical diagnostic products for the early detection and monitoring of chronic diseases and certain medical conditions. Biomerica is FDA registered and CE approved manufacturer of diagnostic tests for laboratories, hospitals, doctor's offices, pharmacies, and consumers. Areas of focus: food intolerance, diabetes, bone/mineral, thyroid, hormones, enteric/stool antigen, kidney function, and infectious disease. Rapid tests for diabetes/microalbumin, fecal occult blood, prostate cancer, breast cancer, h.pylori/ulcers, pregnancy/ovulation, and more.
Bionovax, an API manufacturer with GMP plant, produces Heparin Sodium, Heparin Lithium & LMW Heparin (Enoxaparin) in compliance with TFDA, FDA, EP, and PMDA. Heparinoid is also available for device and cosmetic purposes. Collaborator/broker companies in synergy to develop final dosage forms using our consistent high quality APIs are also welcome.
- Liquid phase peptide synthesis (LPPS)
- Solid phase peptide synthesis
- Peptide purification up to 300 mm DAC columns
- Bulk tray lyophilization
- Process Development
- Analytical Development and Validation
- Process Scale Up
- Reference Standard
- GMP Manufacturing
- Stability Studies
- Regulatory Support
Biophore, an established pharmaceutical company is engaged in the development and manufacture of niche pharmaceutical products for generic industry.Within a decade since inception in 2007, Biophore has emerged as a trusted partner in generic industry across US, Europe and other regulated markets. Biophore's product range is diverse and balanced with NCE, Branded products and grandfather products.
Biophore's portfolio spread across 30 therapeutic segments, is specialized in development and manufacture of pharmaceutical actives for Oncology medications, Contrast and Diagnostic media.
For updated list of products, send an email to [email protected]
Biosearch Life is a leader in biotechnology with a global innovative vocation. We bring innovation in healthy natural ingredients integrating our research, development, production and marketing capacities around three product platforms: Omega-3 (Eupoly-3®), Probiotics (Hereditum®), Botanical Extracts (Exxentia®)
Biosidus is an Argentine-based pioneer in biotechnology which for three decades has been developing and producing top quality recombinant proteins. Since the launch of erythropoetin in 1990, Biosidus has continously increased its worldwide presence, expanding across Latin America, Asia, Africa, Middle East and Eastern Europe. Today, we are selling our products in more than 45 countries worldwide, which includes our own presence in strategic markets through JVs Biosidus's portfolio consists of eight key recombinant human proteins across the therapeutic areas of Nephrology, Hematology, Multiple Sclerosis, Endocrinology, Oncology and Hepatitis: erythropoetin, filgrastim, lenograstim, interferon beta 1a (SC and IM), somatropin, teriparatide, interferon alfa 2a and interferon alfa 2b. Additionally, we have several biosimilars in different stages of development like peg-filgrastim and peg-Interferon beta. We are actively developing orphan drugs like agalsidase. Recently, we have enlarged our portfolio by including small molecules to our Onco-Hematology, Oncology and Immunosuppressive areas to be commercialized in all the territories in which Biosidus is present. Our goal is to basically lead the market of biosimilars and niche products in the emerging countries. Also we are aiming to be actively present with our biosimilars in central countries through partnering with local players. Biosidus is looking for partners to introduce our biosimilar versions of teriparatide and interferon beta 1a in central markets such as USA, Europe and Japan. This approach is based on the highly documented preclinical and clinical development, the large experience after many years in the market and our robust pharmacovigilance programs. Finally, we are intensively seeking for innovative products as well as biosimilars at late stages of development for the following specific therapeutic areas: Oncology, Hematology, Multiple Sclerosis, Growth hormone deficiency, Bone metabolism, Hepatitis, Rheumatoid arthritis, Orphan Drugs and Rare Diseases and other highly specialized therapeutic areas.
Biosynth is a manufacturer and distributor of organic fine chemicals in the field of enzyme substrates, indole derivatives and speciality chemicals for microbiology, molecular biology, diagnostics, pharmaceutical industry, chemical industry, food and environmental testing.
Since 2010 Biotrading has been working too in the field of geriatrics, gastroenterology and oncology, and since 2015 also in sports and veterinary, by investing in R&D, innovation and high quality.
Production processes are certified and special attention is paid to the search for optimal solutions of safety, intake and practicality of the products.
Biotrading bases its production strategy on dynamism, technical and scientific innovation and on the quality of its products .
Micellar solution, a special pharmaceutical technology, is our strength point and it makes the difference of our innovative products.
Our mission is aimed to improve the well-being of the individual by offering and developing high quality and innovative food supplements.
A specific sector study that analyzed the last four financial statements deposited at the Chamber of Commerce places Biotrading in the 21st place among the 39 largest companies in the "Vitamins and Food Supplements" sector in Italy and in the 12th position among the most powerful and successful companies profit margins. Moreover, Biotrading is among the 17 companies that have increased their market value in the last year.
BioVectra is a contract development and manufacturing organization that serves pharmaceutical and biotech companies with full-service cGMP outsourcing solutions for intermediates and active pharmaceutical ingredients (APIs). An innovative and reliable partner with a strong quality history, BioVectra has over 45 years of experience specializing in:
- Microbial Fermentation
- Complex Chemistry
- High-Potency APIs
- Process & Analytical Development
- Drug Development
bisy e.U. - a leading service and technology provider for protein expression in yeasts, Pichia pastoris whole cell biocatalysts kits Cytochrome (CYP) P450 catalysts enzyme expression, antibody expression innovative promoters for yeasts, E. coli and CHO.
bitop AG, a
German company, is focused on the manufacturing and utilization of natural
protective molecules, the so-called Extremolytes.
For more than 20 years, bitop has explored and validated Ectoin®, a naturally-derived molecule with excellent membrane-stabilizing and inflammation-reducing properties for human use. Build on this experience, a portfolio of unique and natural OTC medical devices and cosmetics has been developed. bitop's greatest value lies in the scientifically proven efficacy of its products and the natural and preservative-free formulations.
Ectoin® already proved its efficacy and marketability successfully in various health & wellbeing products which treat and alleviate symptoms of diverse skin diseases (especially atopic dermatitis), cough and cold, allergies and dry epithelia. These products are marketed under brands of experienced pharmaceutical partners in more than 45 countries worldwide by now.
This year, bitop is proud to present its new ophthalmology product range including treatments for blepharitis, as well as new application forms for treatment of dry and allergic eyes. Additionally, bitop will broaden it's dermatology range with medical skin care products for the treatment of e.g. hemorrhoids, vaginal dryness, wound-healing, acne and rosacea.
bitop offers its Ectoin®-containing products on a B2B licensing basis to pharmaceutical companies worldwide.
Blanver is a Brazilian company, founded in 1984, which develops, manufactures and commercializes medicines and active pharmaceutical ingredients (APIs). In medicines, we develop and manufacture high quality products in the HIV, hepatitis and osteoporosis segments, serving patients in Brazil through partnerships with the Ministry of Health and official laboratories.Part of our strategy for expanding our pharmaceutical unit is to expand our presence in the international market through partnerships to export our medicines. We are also looking for strategic alliances with international partners of recognized quality, to license and commercialize innovative and established products in segments such as oncology and hematology in Brazil and Latin America.In APIs, focused on HIV, we are increasing our production and development capacity. Blanver develops, produces and incorporates quality and competitive innovative products in its portfolio, always seeking to promote people's health, quality of life and wellbeing. We operate in the state of São Paulo, with corporate headquarters in the Morumbi neighborhood and two production plants – one in the city of Taboão da Serra, where our medicines are manufactured, and the other in Indaiatuba, for production of APIs. Become our partner, contact us for more information. +55 11 3199-8700 | 4138-8200 | [email protected]
Blau Farmacêutica, is a Brazilian multinational company and a pioneer in the development of recombinant proteins currently producing, bio-pharmaceuticals and Bio-similar selling in Brazil and several countries around the world. The hospital and pharmaceutical Blau line consists on an extensive and varied range of simple and complex products for treatment of several diseases, with 30 years of marketing focused in innovation and technology and with 5 subsidiaries at Latin America: Uruguay, Argentina, Colombia, Chile and Peru and soon will open one more subsidiary in Latin America.
Bliss GVS has niche expertise in the development and manufacturing of suppositories and pessaries, which has been its core business for over three decades. Our manufacturing facility is EU-GMP, PIC/S certified and we offer comprehensive list of products across various therapeutic categories along with formulation development services.We are a public limited company listed on India's National Stock Exchange and Bombay Stock Exchange with more than three decades of industry expertise.We offer contract manufacturing services for suppositories and pessaries.
We are the only EU-GMP certified suppositories manufacturer in India with total installed capacity of 900 million units.
Bloomage Freda Biopharm Co Ltd (formerly Shandong Freda Biopharm Co Ltd) is the global leading manufacturer of Sodium Hyaluronate (HA) with over 20 years experience, supplying high quality HA to the pharmaceutical, cosmetic and health food industry. The company is managed strictly in accordance with GMP and ISO9001 quality system to ensure to reliability and stability of products. Bloomage Freda is the only company in China holding the license for manufacturing pharmaceutical grade HA by fermentation. The company has filed four DMFs (Drug Master Files) for the pharmaceutical grade HA, passed the on-site inspection by US FDA, and obtained CEP certification from EDQM (European Directorate for the Quality of Medicine & HealthCare). The cosmetic grade and food grade HA have received ECOCERT and Kosher certification.
Blue Circle is the leading manufacturer of high
quality X-Ray Contrast Media Intermediates, API Intermediates and Sweeteners/Excipients.
With more than 48 years of manufacturing history, Blue Circle has evolved as
the Strategic Partner for Collaboration, Development and Manufacturing
to global healthcare and Pharma Industry. The company is certified with WHO GMP, ISO-9001, ISO-14001, OHSAS-18001, FSSC-22002 (Food Safety), FAMI-QS (Animal Feed Safety), SA 8000 (Social Accountability), Kosher, Halal. Proactively, the company has also Pre-registered its products with European Chemical Agency (ECA) for the REACH compliance.
Today, the company is the largest manufacturer and exporter of X-Ray Contrast Media Intermediates, API Intermediates and Sweeteners (Saccharin, Sodium Saccharin. Our marketing operations are global which includes USA, Europe, Israel and other regulated markets. We have earned a reputation of a reliable manufacturer and trusted partner across the globe.
Bluepharma is a Portuguese pharmaceutical company resulting from the acquisition of Bayer's former plant in 2001.
Through the entrepreneurship of its promoters, Bluepharma Group currently comprises more than 17 innovative affiliates that cover all stages of the pharmaceutical industry value chain.
Bluepharma's R&D-based strategy allowed to target the most demanding markets of over 40 worldwide territories, representing more than 100 clients and an export rate of 85%.
Bluepharma is FDA approved for the development of solid pharmaceutical forms since 2009, becoming the first Portuguese pharmaceutical company to export to the US market.
Bluepharma offers an integrated approach, from R&D to manufacturing and commercialization of medicines. This is achieved through expertise in formulation, analytical development and scale-up of solid dosage forms as well as through the design of novel platforms (e.g. oral this films and complex injectables) along with dedicated facilities for high potency drugs.This has proven to be determinant in our differatiation and competitiveness.
We aim to create value through innovation.
BMI Korea, regardless of a short history from 2005 in Korean Pharmaceutical industry, has been rapidly growing & connecting into local, worldwide societies for “healthy life of human-being” with the industry's outstanding spotlight & concentration, which is derived from each BMI member's voluntary & creative R&D approach, non-stop challenge & passion, and young but most dynamical corporate's working environment for the future corporate's core value, to jump toward a global player. With a horizontal intergration of BMI's professional experiences, know-hows & novel technologies, BMI- Korea has been always putting all of effort, energy for development of differentiated & novel biopharmaceuticals & medical devices and beyond this, we - on behalf of all BMI members, promise to challenge our goal & dream to care for the best health of every human-being and to become a global leader in 21th century's healthcare industry.
We, BNC Korea Inc., have been accomplishing many achievements through constant R&D activities, since 2006. And we've also carried out preclinical and clinical researches in cooperation with Korea's leading research laboratories. In the affiliated research laboratory which was officially acknowledged by Korea Industrial Technology Association in 2009, a wide range of biocompatible technologies for human are studied hard by utilizing various bio-friendly high-molecular substances, mainly in the biomaterial field. We will keep making every effort to develop more innovative products than yesterday, challenging without a stop and leaping ahead based on the cutting-edge life science technology, just like our motto – Biotechnology, Next Challenge.
Boai NKY Pharmaceuticals Ltd (NKY, stock code: 300109) was the first domestic company to develop and manufacture polyvinylpyrrolidone (PVP) series products in China. With more than 26 years experience in PVP production coupled to a dedicated commitment to quality improvement and management, NKY has become the largest Chinese producer of PVP's and third largest globally.
As leading suppliers of innovative plastics solutions for healthcare, Borealis and Borouge have delivered value creation through innovation to their customers for over 30 years. Building on their Bormed™ product portfolio and the principles of the Bormed Concept – Commitment, Service and Conformance – they offer advanced polyolefins for medical devices, pharmaceutical and diagnostic packaging. Their solutions provide superior technical performance and fulfil the most stringent requirements for safety and quality. Their long-term commitment to address tomorrow's healthcare challenges makes them a reliable and trusted partner and has led to receiving the 2016 Frost & Sullivan Growth Excellence leadership Award.
BorsodChem MCHZ, s.r.o. is one of three BorsodChem's production facilities in Central Europe. We supply a range of mostly organic, but also inorganic chemical products. The raw materials developed here are used by the PU, rubber, pharmaceutical, agriculture and beverage industries as well as water treatment plants.
Almost all of our output is exported. We provide substantial aniline supplies to our parent company in Hungary. Other products are distributed throughout Europe and further afield, including Asia and The Americas.
Boryung Pharmaceutical Company, aiming to be the best not the biggest, started since 1957 and has put a strong presence in Korean market as one of TOP leading pharmaceutical companies.
Boryung has invested continually on research and development and made
continuous efforts to produce high-quality products. Lately by
new drug, Fimasartan (8th
Angiotensin Receptor Blocker over the world) with its own R&D,Boryung
is accelerating its R&D activity to become the global health care company.
Boryung has continued to expand the global network and now, it's partners and markets cover Japan, China, ASEAN, Europe, Latin America, Middle East, and Africa.
BOSCOGEN® Inc is dedicated to the manufacturing, marketing, and distribution of premium quality nutritional supplements, including vitamins, minerals, and herbals. Our long term experience and expertise gives us the edge in researching and developing innovative products and unrivaled excellence.
Boston Biopharma is a US-based pharmaceutical company that specializes in providing the highest quality specialty medications worldwide, in particular to emerging countries. We do this through pioneering R&D, and licensing, manufacturing, and commercializing the finest therapeutics especially oncology, multiple sclerosis, and immunology. Our EMEA operations office is located in Malta and we have a significant market presence in Algeria, Iraq, and the GCC. With a focus on product quality and operational flexibility, our firm brings decades of healthcare industry expertise to some of the most difficult markets.
Boston Nutraceutical Science (BNS) is a Spanish-owned company integrated in the Damel Group which operates in the food industry. BNS is the Health Care, Vitamin, Diet & Nutrition division created by Damel Group to develop their own concept of Fortified Food in the four production plants based in Spain.
Founded in 1952, BOTTU ranks first in the Moroccan market in volume with more than 40 Million units produced per year. Besides Marketing its own portfolio of Generic products, BOTTU markets products under License Agreements of renowned Multinational Companies. Export-oriented since 2008, BOTTU is developing its business in Africa, GCC, CIS..
Water treatment systems: water pre-treatment systems, reverse osmosis, vapor compression or multiple effect distillers, pure steam generators, distribution systems, control systems, heat/cool exchangers, storage tanks, standard accessories and components. Filling and packaging lines: filling machines for bags and bottles, stretch-blow-molding machines for pp bottles, form fill seal equipment for bags. Processing technologies: turnkey pharmaceutical plants, water treatment systems, processing systems, filling and packaging lines etc. Turnkey pharmaceutical projects: plants for I.V. solutions and plants for dialysis products.
Braunform at a Glance. Founded in 1977, Braunform is considered to be one of the most innovative service providers of injection mold technology in the plastics processing industry today. The fully air-conditioned mold shop is characterized as an ideal partner for new product ideas as well as by its high technological competence in the sector of pharmaceutical applications, demonstrated by the development of dedicated solutions for this sector like its recognized MED-mold® standard. The company is specialized in the manufacturing of multi-component and high precision molds especially for the pharmaceutical industry, stack molds, as well as fast rotary tables. For the pharmaceutical industry Braunform also offers sophisticated processes in clean rooms GMP C and D. In the Technology Center, customers may use injection mold machines with 2 component (with silicone injection) and 3 component applications for pre-series manufacturing. Development times and costs are reduced considerably by handling projects in the manner of Full Service Engineering and Value Added Service. The main focus is always on process assurance, shorter cycle times, increasing output quantities and all at the highest of quality - Made in Germany.
Brenntag is the global market-leader in full-line chemical distribution, linking chemical manufacturers and chemical users. Brenntag provides business-to-business distribution solutions for industrial and specialty chemicals globally. With over 10,000 products and a world-class supplier base, Brenntag is a full-line distributor to more than 170,000 customers worldwide. Headquartered in Mülheim an der Ruhr, Germany, Brenntag operates a global network of more than 480 locations in over 70 countries worldwide and with about 210 distribution centers in over 30 countries across Europe.
Bright Way Group is one of the leading Russian pharmaceutical company. We have 20 years of experience in the market as distributor of the Active Pharmaceutical Ingredients at the territory of Russian Federation; Over than 200 APIs had been registered at the Russian Federation by our side, we successfully realized a lot of commercial sales and have a positive relationship with reliable partners globally. We have our own Office as well as Registration Bureau and warehouse facilities; At present we are also involved in several governmental projects. We are actively working to expand the business and at the moment we have our own production plant of Finished Formulations, and we realize the project of building a new plant in the Moscow region. The project is implemented with the active support of the Russian government. We are looking for partnerships that can create new opportunities for business expansion in other countries and regions. Our main activities are: Promotion and Distribution of APIs, FDF, veterinary medicines, equipment, cosmetics. Production of FDF in Russia. Contract manufacturing. Localization of FDF production in Russia. Technology transfer. Localization of API production in Russia. Manufacturer/supplierFinished Dosage FormulationCountries: Russia - EuropeFinished Dosage FormulationCountries: Russia - Europe FDFContract ServicePharmaceutical Services Countries: Russia - Europe Packaging and LogisticsCountries: Russia - Europe
BrightGene Bio-medical Technology Co Ltd is a fast-growing biopharmaceutical company that engages in the research, development and manufacturing of Active Pharmaceutical Ingredients and Intermediates with primary focus on the high-end API market and late-stage drug candidates. Our main products include:- Entecavir, Pemetrexed, Argatroban, Caspofungin, Anidulafungin, Micafungin,and Saxagliptin, Posaconazole so on.
Established in 1997, Bristol Laboratories is a fast growing British pharmaceutical company engaged in the development, manufacture, marketing and distribution of generic medicines in the UK and Europe.